Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 18 | 18 | 418 | 18 | 18 |
| Gross Profit | 18 | 18 | 418 | 18 | 18 |
| Operating Expenses | 336 | 349 | 318 | 315 | 371 |
| Operating Income | -317 | -331 | 101 | -297 | -353 |
| Interest Expense | 4 | 1 | 117 | 116 | 111 |
| Other Income | 0 | 0 | 256 | 49 | -56 |
| Pre-tax Income | -321 | -332 | 239 | -363 | -520 |
| Net Income Continuous | -321 | -332 | 239 | -363 | -520 |
| Net Income | $-321 | $-332 | $239 | $-363 | $-520 |
| EPS Basic Total Ops | -50.00 | -50.00 | 50.00 | -50.00 | -100.00 |
| EPS Basic Continuous Ops | -52.39 | -54.19 | 39.01 | -59.19 | -84.88 |
| EPS Diluted Total Ops | -50.00 | -50.00 | 50.00 | -50.00 | -100.00 |
| EPS Diluted Continuous Ops | -52.39 | -54.19 | 39.01 | -59.19 | -84.88 |
| EBITDA(a) | $-317 | $-331 | $101 | $-297 | $-353 |